3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Leukemia, Myeloid, Acute
71
Precursor Cell Lymphoblastic Leukemia-Lymphoma
21
Leukemia, Biphenotypic, Acute
14
Recurrence
13
Myelodysplastic Syndromes
13
Leukemia
12
Burkitt Lymphoma
11
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
7
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
7
Leukemia, Myelomonocytic, Chronic
6
Lymphoma, Mantle-Cell
5
Neoplasm, Residual
4
Myeloproliferative Disorders
4
Lymphoma, Large B-Cell, Diffuse
4
Hodgkin Disease
4
Hematologic Neoplasms
4
Sarcoma, Myeloid
3
Lymphoma, T-Cell
3
Lymphoma
3
Blast Crisis
3
Lymphoma, Non-Hodgkin
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myeloid
2
Down Syndrome
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Anemia, Refractory, with Excess of Blasts
2
Targeted Therapy
1
Pyloric Stenosis, Hypertrophic
1
Neurofibromatosis 1
1
Neoplasms by Histologic Type
1
Interventions
lutetium Lu 177 dotatate
2
Temozolomide
2
ONC206
2
Etoposide
2
Cyclophosphamide
2
Bevacizumab
2
olaparib
1
neratinib
1
ibrutinib
1
fenofibric acid
1
etoposide phosphate
1
brigatinib
1
Watchful Waiting
1
Thalidomide
1
Restraint, Physical
1
Radiotherapy
1
Radiation
1
Magnetic Resonance Spectroscopy
1
Linear Energy Transfer
1
Irinotecan
1
Elasticity Imaging Techniques
1
Cytarabine
1
Celecoxib
1
Automobiles
1
1-methyltryptophan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Ependymoma
×
Cytarabine
×
Clear all
NCT01356290
2026-02-23
MEMMAT
Medical University of Vienna
Phase 2
Recruiting
232 enrolled